ABSTRACT
Objectives Clinicians have little guidance on the time needed before assessing the effect of a mean airway pressure (PAW) change during high-frequency oscillatory ventilation (HFOV). We aimed to determine 1) time to stable lung volume after a PAW change during HFOV and, 2) the relationship between time to volume stability and the volume state of the lung.
Methods Continuous lung volume measurements (respiratory inductive plethysmography) after 1-2 cmH2O PAW changes made every 10 minutes during an open lung strategy (n=13 infants) were analysed with a bi-exponential model. Time to stable lung volume (extrapolated to maximum 3600s) was calculated if the model R2 was >0.6.
Results 196 PAW changes were made, with no volume change in 33 (17%) occurrences. 125 volume signals met modelling criteria for inclusion; median (IQR) R2 0.96 (0.91, 0.98). The time to stable lung volume was 1131 (718, 1959)s (PAW increases) and 647 (439, 1309)s (PAW decreases), with only 17 (14%) occurring within 10 minutes and time to stability being longer when the lung was atelectatic.
Conclusions During HFOV, the time to stable lung volume after a PAW change is variable, often requires more than 10 minutes and is dependent on the preceding volume state.
Impact Statement
In infants without preterm respiratory distress syndrome the time to achieve lung volume stability after a PAW change during HFOV is usually greater than 10 minutes.
The volume state of the lung at the time of PAW change influences the time required to achieve a stable new lung volume; being shorter when the lung is well recruited and longer when the lung is already atelectatic.
Clinicians should be aware that it may require least 10 minutes before assessing the clinical response to a change in PAW during HFOV
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DGT was supported by a National Health and Medical Research Council Clinical Research Fellowship (Grant ID 491286 and 1053889). DGT, NK and JFM are supported by the Victorian Government Operational Infrastructure Support Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Royal Childrens Hospital Human Ethics Committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest and Source of Funding: DGT was supported by a National Health and Medical Research Council Clinical Research Fellowship (Grant ID 491286 and 1053889). DGT, NK and JFM are supported by the Victorian Government Operational Infrastructure Support Program. None of the authors have any conflict of interest to disclose.
Category of Study: Clinical (observational)
Consent Statement: Prospective written informed parental consent was obtained for each infant prior to enrolment in the study.
Data Sharing: Individual participant data collected during the study, after de-identification, and study protocols and statistical analysis code are available beginning 3 months and ending 23 years following article publication to researchers who provide a methodological sound proposal, with approval by an independent review committee (“learned intermediatry”) identified for purpose. Data is available for analysis to achieve aims in the approved proposal. Proposals should be directed to david.tingay{at}mcri.edu.au; to gain access, data requestors will need to sign a data access or material transfer agreement approved by the Murdoch Children’s Research Institute.
Data Availability
Individual participant data collected during the study, after de-identification, and study protocols and statistical analysis code are available beginning 3 months and ending 23 years following article publication to researchers who provide a methodological sound proposal, with approval by an independent review committee (learned intermediatry) identified for purpose. Data is available for analysis to achieve aims in the approved proposal. Proposals should be directed to david.tingay@mcri.edu.au; to gain access, data requestors will need to sign a data access or material transfer agreement approved by the Murdoch Childrens Research Institute.